Search

Accessing new eye therapies, protecting vision, improving patients' comfort, developing breaktrough treatments

Home

You are here : Home

Novagali Pharma - Accessing new eye Therapies

Novagali Pharma is an emerging ophthalmic pharmaceutical company that develops innovative products for all segments of the eye.

The company has developed a broad pipeline of innovative products addressing main ocular conditions as well as orphan diseases, thanks to its proprietary technology platforms Novasorb® and Eyeject®.

Novagali Pharma on LCI

30st January 2010, clic here to see the video (new window)

 

 

Cationorm launched in Italy

EVRY – 15 Februay 2010 Novagali launches Cationorm® in Italy in collaboration with Eupharmed laboratories.

 Cationorm Italy

For more information, please send an email to m.alfano@petrone.it 

Read more about Cationorm®

Interview of Jérôme Martinez, CEO

8th July 2010, clic here to see the video (new window)

Interview

 

 

Cationorm launched in Lebanon

EVRY – 19 April 2010 Novagali launches Cationorm® in Lebanon in collaboration with KETTANEH laboratories.

Liban lancement

For more information, please send an email to pharma@kettaneh.com

Read more about Cationorm®

 

 

Discover Cationorm®

Cationorm

An innovative cationic emulsion to relieve dry eye sensation 

  • Moisturization
  • Lubrication
  • Protection

of the eye surface

 Read more

 

Accessibility Focus

Our commitment to make our site accessible to anyone is based on the WCAG standards. Would you have any suggestion or request do not hesitate to contact us: Make a suggestion.

Choose your language